MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.
暂无分享,去创建一个
Lars Bullinger | Andrew L Kung | Scott A Armstrong | S. Armstrong | L. Bullinger | A. Kung | Zhaohui Feng | A. Sinha | A. Krivtsov | J. Faber | R. Pollock | N. Zhu | V. Richon | K. Bernt | Roy M Pollock | Kathrin M Bernt | Nan Zhu | Amit U Sinha | Sridhar Vempati | Joerg Faber | Andrei V Krivtsov | Zhaohui Feng | Natalie Punt | Amanda Daigle | Victoria M Richon | S. Vempati | Natalie Punt | Amanda Daigle | Joerg Faber | Nan Zhu | S. Armstrong
[1] DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. , 2011, Blood.
[2] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[3] N. Zeleznik-Le,et al. Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes. , 2010, Cancer research.
[4] Xiaobo Xia,et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. , 2008, Cancer cell.
[5] C. Allis,et al. Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.
[6] T. Golub,et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.
[7] J. Issa,et al. DNA Methylation as a Therapeutic Target in Cancer , 2007, Clinical Cancer Research.
[8] Dafydd G. Thomas,et al. Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. , 2011, Blood.
[9] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[10] H. Broxmeyer,et al. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. , 1991, Cancer cells.
[11] Arndt Borkhardt,et al. Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization , 2004, Molecular and Cellular Biology.
[12] Wolfram Goessling,et al. The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML , 2010, Science.
[13] Laurence Florens,et al. Histone Crosstalk between H2B Monoubiquitination and H3 Methylation Mediated by COMPASS , 2007, Cell.
[14] Axel Benner,et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.
[15] Toshiki Mori,et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. , 2002, Molecular cell.
[16] Joshua F. McMichael,et al. DNMT3A mutations in acute myeloid leukemia. , 2010, The New England journal of medicine.
[17] Thomas A Milne,et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. , 2002, Molecular cell.
[18] Yi Zhang,et al. Structure of the Catalytic Domain of Human DOT1L, a Non-SET Domain Nucleosomal Histone Methyltransferase , 2003, Cell.
[19] C. Bach,et al. Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia , 2009, PLoS biology.
[20] E. Lander,et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.
[21] K. Davies,et al. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. , 2007, Human molecular genetics.
[22] H. Drexler,et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders , 2010, Nature Genetics.
[23] R. Kuiper,et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes , 2010, Nature Genetics.
[24] K. Helin,et al. Histone methyltransferases in cancer. , 2010, Seminars in cell & developmental biology.
[25] A. Shilatifard,et al. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. , 2010, Molecular cell.
[26] S. Gore,et al. DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes. , 2008, Seminars in hematology.
[27] M. Groudine,et al. H3 K79 dimethylation marks developmental activation of the beta-globin gene but is reduced upon LCR-mediated high-level transcription. , 2008, Blood.
[28] J. Downing,et al. Gene Expression Profiling of Pediatric Acute Myelogenous Leukemia Materials and Methods , 2022 .
[29] T. Fields,et al. Early mammalian erythropoiesis requires the Dot1L methyltransferase. , 2010, Blood.
[30] Christopher R. Vakoc,et al. DOT1L/KMT4 Recruitment and H3K79 Methylation Are Ubiquitously Coupled with Gene Transcription in Mammalian Cells , 2008, Molecular and Cellular Biology.
[31] De-Pei Liu,et al. A conserved, extended chromatin opening within α-globin locus during development , 2005 .
[32] Yi Zhang,et al. hDOT1L Links Histone Methylation to Leukemogenesis , 2005, Cell.
[33] Jiaying Tan,et al. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. , 2010, Cancer cell.
[34] A. Shilatifard,et al. Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). , 2010, Genes & development.
[35] A. Chinnaiyan,et al. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. , 2007, Blood.
[36] Wenzheng Zhang,et al. Dot1a-AF9 Complex Mediates Histone H3 Lys-79 Hypermethylation and Repression of ENaCα in an Aldosterone-sensitive Manner* , 2006, Journal of Biological Chemistry.
[37] Scott A. Armstrong,et al. MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.
[38] J. Hess,et al. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. , 2005, Cancer research.
[39] Ali Shilatifard,et al. Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis , 2010, Nature Reviews Cancer.
[40] Mark Johnston,et al. Linking cell cycle to histone modifications: SBF and H2B monoubiquitination machinery and cell-cycle regulation of H3K79 dimethylation. , 2009, Molecular cell.
[41] Richard A Young,et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. , 2008, Genes & development.
[42] M. Cleary,et al. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins , 2001, Oncogene.
[43] R. Humphries,et al. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells , 1999, Leukemia.
[44] Kristian Helin,et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. , 2006, Genes & development.
[45] De-Pei Liu,et al. A conserved, extended chromatin opening within alpha-globin locus during development. , 2005, Experimental cell research.
[46] M. Cleary,et al. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. , 2010, Cancer cell.
[47] D. Charnock-Jones,et al. vavCre Transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages , 2002, Genesis.